{"id":43304,"date":"2020-07-21T21:54:03","date_gmt":"2020-07-21T19:54:03","guid":{"rendered":"https:\/\/newserver.fyb.de\/pp-poellath-partners-advises-zur-rose-group-on-the-acquisition-of-teleclinic\/"},"modified":"2020-07-21T21:54:03","modified_gmt":"2020-07-21T19:54:03","slug":"pp-poellath-partners-advises-zur-rose-group-on-the-acquisition-of-teleclinic","status":"publish","type":"post","link":"https:\/\/www.fyb.de\/en\/pp-poellath-partners-advises-zur-rose-group-on-the-acquisition-of-teleclinic\/","title":{"rendered":"P+P P\u00f6llath + Partners advises Zur Rose Group on the acquisition of TeleClinic"},"content":{"rendered":"

Munich \u2014 The Zur Rose Group<\/strong> has acqui\u00adred Tele\u00adCli\u00adnic<\/strong> GmbH (\u201cTele\u00adCli\u00adnic\u201d), based in Munich, for a purchase price in the mid double-digit million euro range.<\/p>\n

Tele\u00adCli\u00adnic was foun\u00added in 2015 by Katha\u00adrina J\u00fcnger and has quickly estab\u00adlished itself as the leading tele\u00adme\u00addi\u00adcine provi\u00adder in Germany. The company provi\u00addes tele\u00adme\u00addi\u00adcine services, inclu\u00adding digi\u00adtal prescrip\u00adti\u00adons and dise\u00adase certi\u00adfi\u00adca\u00adtes that are compli\u00adant with German health insu\u00adrance reim\u00adbur\u00adse\u00adment regu\u00adla\u00adti\u00adons. After a diagno\u00adsis by a specia\u00adlist, pati\u00adents who are self-paying receive an e\u2011prescription based on a Tele\u00adCli\u00adnic solu\u00adtion via app on their cell phone, which they can redeem at an on-site or mail-order phar\u00admacy. Online sick notes can be sent directly to the employer via email. Doctors can join the plat\u00adform easily and without obli\u00adga\u00adtion and offer their exper\u00adtise flexi\u00adbly and regard\u00adless of location.<\/p>\n

The Swiss Zur Rose Group is Euro\u00adpe\u2019s largest e\u2011commerce phar\u00admacy and one of the leading medi\u00adcal whole\u00adsa\u00adlers in Switz\u00ader\u00adland. It also opera\u00adtes the leading market\u00adplace in Southern Europe for phar\u00admacy-bran\u00added health and perso\u00adnal care products. The company has an inter\u00adna\u00adtio\u00adnal presence, inclu\u00adding Germany\u2019s best-known phar\u00admacy brand DocMor\u00adris. Zur Rose employs more than 1,800 people at its sites in Switz\u00ader\u00adland, Germany, the Nether\u00adlands, Spain and France. In 2019, it gene\u00adra\u00adted sales of 1,569 million Swiss francs (inclu\u00adding medpex) at<\/p>\n

Advi\u00adsor Zur Rose Group: P+P P\u00f6llath + Partners <\/strong>
\nDr. Michael Inhes\u00adter (Part\u00adner, Lead Part\u00adner, M&A, Munich)
\nAdal\u00adbert Makos (Coun\u00adsel, M&A, Munich)
\nDaniel Wied\u00admann, LL.M. (NYU) (Asso\u00adcia\u00adted Part\u00adner, Anti\u00adtrust Law, Frankfurt)
\nMatthias Ober\u00adbauer (Asso\u00adciate, M&A, Munich)<\/p>\n","protected":false},"excerpt":{"rendered":"

Munich \u2014 The Zur Rose Group has acqui\u00adred Tele\u00adCli\u00adnic GmbH (\u201cTele\u00adCli\u00adnic\u201d), based in Munich, for a purchase price in the mid double-digit million euro range. Tele\u00adCli\u00adnic was foun\u00added in 2015 by Katha\u00adrina J\u00fcnger and has quickly estab\u00adlished itself as the leading tele\u00adme\u00addi\u00adcine provi\u00adder in Germany. The company provi\u00addes tele\u00adme\u00addi\u00adcine services, inclu\u00adding digi\u00adtal prescrip\u00adti\u00adons and dise\u00adase certificates [\u2026]<\/p>\n","protected":false},"author":2,"featured_media":35075,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"wp_typography_post_enhancements_disabled":false,"footnotes":""},"categories":[886,1364,1366,1367,1368,1372],"tags":[],"class_list":["post-43304","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-general-en","category-featured-en","category-news-en","category-lawyers-tax-advisors-auditors-en","category-lawyers-tax-consultants-auditors","category-consultant","news-category-deals-news-en"],"yoast_head":"\nP+P P\u00f6llath + Partners advises Zur Rose Group on the acquisition of TeleClinic - FYB Financial Yearbook<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.fyb.de\/en\/pp-poellath-partners-advises-zur-rose-group-on-the-acquisition-of-teleclinic\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"P+P P\u00f6llath + Partners advises Zur Rose Group on the acquisition of TeleClinic - FYB Financial Yearbook\" \/>\n<meta property=\"og:description\" content=\"Munich \u2014 The Zur Rose Group has acqui\u00adred Tele\u00adCli\u00adnic GmbH (\u201cTele\u00adCli\u00adnic\u201d), based in Munich, for a purchase price in the mid double-digit million euro range. Tele\u00adCli\u00adnic was foun\u00added in 2015 by Katha\u00adrina J\u00fcnger and has quickly estab\u00adlished itself as the leading tele\u00adme\u00addi\u00adcine provi\u00adder in Germany. The company provi\u00addes tele\u00adme\u00addi\u00adcine services, inclu\u00adding digi\u00adtal prescrip\u00adti\u00adons and dise\u00adase certi\u00adfi\u00adca\u00adtes […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.fyb.de\/en\/pp-poellath-partners-advises-zur-rose-group-on-the-acquisition-of-teleclinic\/\" \/>\n<meta property=\"og:site_name\" content=\"FYB Financial Yearbook\" \/>\n<meta property=\"article:published_time\" content=\"2020-07-21T19:54:03+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/07\/a-inhester-michael_2.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"379\" \/>\n\t<meta property=\"og:image:height\" content=\"251\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Tatjana Anderer\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Tatjana Anderer\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.fyb.de\/en\/pp-poellath-partners-advises-zur-rose-group-on-the-acquisition-of-teleclinic\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.fyb.de\/en\/pp-poellath-partners-advises-zur-rose-group-on-the-acquisition-of-teleclinic\/\"},\"author\":{\"name\":\"Tatjana Anderer\",\"@id\":\"https:\/\/www.fyb.de\/en\/#\/schema\/person\/4308b3086925bc8567ceba3ebd69b4ce\"},\"headline\":\"P+P P\u00f6llath + Partners advises Zur Rose Group on the acquisition of TeleClinic\",\"datePublished\":\"2020-07-21T19:54:03+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.fyb.de\/en\/pp-poellath-partners-advises-zur-rose-group-on-the-acquisition-of-teleclinic\/\"},\"wordCount\":263,\"publisher\":{\"@id\":\"https:\/\/www.fyb.de\/en\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.fyb.de\/en\/pp-poellath-partners-advises-zur-rose-group-on-the-acquisition-of-teleclinic\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/07\/a-inhester-michael_2.jpg\",\"articleSection\":[\"General\",\"Featured\",\"News\",\"Lawyers\/Tax-advisors\/Auditors\",\"Lawyers, tax consultants, auditors\",\"Consultant\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.fyb.de\/en\/pp-poellath-partners-advises-zur-rose-group-on-the-acquisition-of-teleclinic\/\",\"url\":\"https:\/\/www.fyb.de\/en\/pp-poellath-partners-advises-zur-rose-group-on-the-acquisition-of-teleclinic\/\",\"name\":\"P+P P\u00f6llath + Partners advises Zur Rose Group on the acquisition of TeleClinic - FYB Financial Yearbook\",\"isPartOf\":{\"@id\":\"https:\/\/www.fyb.de\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.fyb.de\/en\/pp-poellath-partners-advises-zur-rose-group-on-the-acquisition-of-teleclinic\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.fyb.de\/en\/pp-poellath-partners-advises-zur-rose-group-on-the-acquisition-of-teleclinic\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/07\/a-inhester-michael_2.jpg\",\"datePublished\":\"2020-07-21T19:54:03+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.fyb.de\/en\/pp-poellath-partners-advises-zur-rose-group-on-the-acquisition-of-teleclinic\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.fyb.de\/en\/pp-poellath-partners-advises-zur-rose-group-on-the-acquisition-of-teleclinic\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.fyb.de\/en\/pp-poellath-partners-advises-zur-rose-group-on-the-acquisition-of-teleclinic\/#primaryimage\",\"url\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/07\/a-inhester-michael_2.jpg\",\"contentUrl\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/07\/a-inhester-michael_2.jpg\",\"width\":379,\"height\":251},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.fyb.de\/en\/pp-poellath-partners-advises-zur-rose-group-on-the-acquisition-of-teleclinic\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.fyb.de\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"P+P P\u00f6llath + Partners advises Zur Rose Group on the acquisition of TeleClinic\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.fyb.de\/en\/#website\",\"url\":\"https:\/\/www.fyb.de\/en\/\",\"name\":\"FYB Financial Yearbook\",\"description\":\"For Your Business\",\"publisher\":{\"@id\":\"https:\/\/www.fyb.de\/en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.fyb.de\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.fyb.de\/en\/#organization\",\"name\":\"FYB Financial Yearbook\",\"url\":\"https:\/\/www.fyb.de\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.fyb.de\/en\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/06\/logo.svg\",\"contentUrl\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/06\/logo.svg\",\"caption\":\"FYB Financial Yearbook\"},\"image\":{\"@id\":\"https:\/\/www.fyb.de\/en\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.fyb.de\/en\/#\/schema\/person\/4308b3086925bc8567ceba3ebd69b4ce\",\"name\":\"Tatjana Anderer\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.fyb.de\/en\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/11708a5289b743e6290bae8e4109e97efec1cb1ae5c7065f0bfc5c36f28c7757?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/11708a5289b743e6290bae8e4109e97efec1cb1ae5c7065f0bfc5c36f28c7757?s=96&d=mm&r=g\",\"caption\":\"Tatjana Anderer\"},\"description\":\"Gr\u00fcnderin des FYB-Verlag\",\"sameAs\":[\"http:\/\/neu.fyb.de\"],\"url\":\"https:\/\/www.fyb.de\/en\/author\/tanderer\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"P+P P\u00f6llath + Partners advises Zur Rose Group on the acquisition of TeleClinic - FYB Financial Yearbook","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.fyb.de\/en\/pp-poellath-partners-advises-zur-rose-group-on-the-acquisition-of-teleclinic\/","og_locale":"en_US","og_type":"article","og_title":"P+P P\u00f6llath + Partners advises Zur Rose Group on the acquisition of TeleClinic - FYB Financial Yearbook","og_description":"Munich \u2014 The Zur Rose Group has acqui\u00adred Tele\u00adCli\u00adnic GmbH (\u201cTele\u00adCli\u00adnic\u201d), based in Munich, for a purchase price in the mid double-digit million euro range. Tele\u00adCli\u00adnic was foun\u00added in 2015 by Katha\u00adrina J\u00fcnger and has quickly estab\u00adlished itself as the leading tele\u00adme\u00addi\u00adcine provi\u00adder in Germany. The company provi\u00addes tele\u00adme\u00addi\u00adcine services, inclu\u00adding digi\u00adtal prescrip\u00adti\u00adons and dise\u00adase certi\u00adfi\u00adca\u00adtes […]","og_url":"https:\/\/www.fyb.de\/en\/pp-poellath-partners-advises-zur-rose-group-on-the-acquisition-of-teleclinic\/","og_site_name":"FYB Financial Yearbook","article_published_time":"2020-07-21T19:54:03+00:00","og_image":[{"width":379,"height":251,"url":"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/07\/a-inhester-michael_2.jpg","type":"image\/jpeg"}],"author":"Tatjana Anderer","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Tatjana Anderer","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.fyb.de\/en\/pp-poellath-partners-advises-zur-rose-group-on-the-acquisition-of-teleclinic\/#article","isPartOf":{"@id":"https:\/\/www.fyb.de\/en\/pp-poellath-partners-advises-zur-rose-group-on-the-acquisition-of-teleclinic\/"},"author":{"name":"Tatjana Anderer","@id":"https:\/\/www.fyb.de\/en\/#\/schema\/person\/4308b3086925bc8567ceba3ebd69b4ce"},"headline":"P+P P\u00f6llath + Partners advises Zur Rose Group on the acquisition of TeleClinic","datePublished":"2020-07-21T19:54:03+00:00","mainEntityOfPage":{"@id":"https:\/\/www.fyb.de\/en\/pp-poellath-partners-advises-zur-rose-group-on-the-acquisition-of-teleclinic\/"},"wordCount":263,"publisher":{"@id":"https:\/\/www.fyb.de\/en\/#organization"},"image":{"@id":"https:\/\/www.fyb.de\/en\/pp-poellath-partners-advises-zur-rose-group-on-the-acquisition-of-teleclinic\/#primaryimage"},"thumbnailUrl":"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/07\/a-inhester-michael_2.jpg","articleSection":["General","Featured","News","Lawyers\/Tax-advisors\/Auditors","Lawyers, tax consultants, auditors","Consultant"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.fyb.de\/en\/pp-poellath-partners-advises-zur-rose-group-on-the-acquisition-of-teleclinic\/","url":"https:\/\/www.fyb.de\/en\/pp-poellath-partners-advises-zur-rose-group-on-the-acquisition-of-teleclinic\/","name":"P+P P\u00f6llath + Partners advises Zur Rose Group on the acquisition of TeleClinic - FYB Financial Yearbook","isPartOf":{"@id":"https:\/\/www.fyb.de\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.fyb.de\/en\/pp-poellath-partners-advises-zur-rose-group-on-the-acquisition-of-teleclinic\/#primaryimage"},"image":{"@id":"https:\/\/www.fyb.de\/en\/pp-poellath-partners-advises-zur-rose-group-on-the-acquisition-of-teleclinic\/#primaryimage"},"thumbnailUrl":"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/07\/a-inhester-michael_2.jpg","datePublished":"2020-07-21T19:54:03+00:00","breadcrumb":{"@id":"https:\/\/www.fyb.de\/en\/pp-poellath-partners-advises-zur-rose-group-on-the-acquisition-of-teleclinic\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.fyb.de\/en\/pp-poellath-partners-advises-zur-rose-group-on-the-acquisition-of-teleclinic\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.fyb.de\/en\/pp-poellath-partners-advises-zur-rose-group-on-the-acquisition-of-teleclinic\/#primaryimage","url":"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/07\/a-inhester-michael_2.jpg","contentUrl":"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/07\/a-inhester-michael_2.jpg","width":379,"height":251},{"@type":"BreadcrumbList","@id":"https:\/\/www.fyb.de\/en\/pp-poellath-partners-advises-zur-rose-group-on-the-acquisition-of-teleclinic\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.fyb.de\/en\/"},{"@type":"ListItem","position":2,"name":"P+P P\u00f6llath + Partners advises Zur Rose Group on the acquisition of TeleClinic"}]},{"@type":"WebSite","@id":"https:\/\/www.fyb.de\/en\/#website","url":"https:\/\/www.fyb.de\/en\/","name":"FYB Financial Yearbook","description":"For Your Business","publisher":{"@id":"https:\/\/www.fyb.de\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.fyb.de\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.fyb.de\/en\/#organization","name":"FYB Financial Yearbook","url":"https:\/\/www.fyb.de\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.fyb.de\/en\/#\/schema\/logo\/image\/","url":"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/06\/logo.svg","contentUrl":"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/06\/logo.svg","caption":"FYB Financial Yearbook"},"image":{"@id":"https:\/\/www.fyb.de\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.fyb.de\/en\/#\/schema\/person\/4308b3086925bc8567ceba3ebd69b4ce","name":"Tatjana Anderer","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.fyb.de\/en\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/11708a5289b743e6290bae8e4109e97efec1cb1ae5c7065f0bfc5c36f28c7757?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/11708a5289b743e6290bae8e4109e97efec1cb1ae5c7065f0bfc5c36f28c7757?s=96&d=mm&r=g","caption":"Tatjana Anderer"},"description":"Gr\u00fcnderin des FYB-Verlag","sameAs":["http:\/\/neu.fyb.de"],"url":"https:\/\/www.fyb.de\/en\/author\/tanderer\/"}]}},"_links":{"self":[{"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/posts\/43304","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/comments?post=43304"}],"version-history":[{"count":0,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/posts\/43304\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/media\/35075"}],"wp:attachment":[{"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/media?parent=43304"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/categories?post=43304"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/tags?post=43304"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}